Penn Medicine's Abramson Cancer Center incorporates a bench to bedside approach to treating cancer that keeps providers at the patient's bedside connected to the researchers in the lab developing the therapies. In this video Dr. Robert Vonderheide, Director of the Abramson Cancer Center explains what bench to bedside means and how it impacts the patients treated at Penn.
Twitter @PennMDForum
Related Presenters
Medical Oncology
Dr. Vonderheide is an internationally renowned cancer immunotherapy and translational research expert. Through a focus on novel immunotherapies for pancreatic cancer, melanoma and breast cancers, Dr. Vonderheide has mapped new models for ...
Related Videos
